In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.
The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004
Restrictions in Texas' medical cannabis law keep most of the state's patients from participating. Our survey of 2,866 Texas residents who use medical cannabis sought to gain insight into the needs and experiences of this population.
The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal
Anaeze C. Offodile II, Chris Sidey-Gibbons, André Pfob, Malke Assad, Stefanos Boukovalas, Yu-Li Lin, Jesse Creed Selber, Charles ButlerMarch 26, 2021
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy SugarmanFebruary 26, 2021
Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.
Katharine Neill Harris, William MartinFebruary 5, 2021
This study leverages validated patient-reported outcomes measures to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons
Anaeze C. Offodile II, Christopher J. Coroneos, Yu-Li Lin, Chris Sidey-Gibbons, Malke Asaad, Brian Chin, Stefanos Boukovalas, Margaret S. Roubaud, Makesha Miggins, Donald P. BaumannDecember 21, 2020
Over the past decade, anti-vaccine rhetoric and activity have increased in the United States, resulting in decreased vaccination rates and more frequent outbreaks of vaccine-preventable diseases. In this study, researchers use Texas as a case study to determine if vaccine-related legislation became a partisan issue between 2009 and 2019.
Sarah Lasater, Rekha Lakshmanan, Kirstin R.W. MatthewsNovember 30, 2020
To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.
Kirstin R.W. Matthews, Daniel MoralíAugust 17, 2020